(Q42967157)

11 November 2017

NSAIDs and risk of lower gastrointestinal bleeding (English)

1 reference

11 November 2017

2

Sasha Bernatsky

1 reference

11 November 2017

Elham Rahme

1

1 reference

PubMed ID

20638554

11 November 2017

language of work or name

English

0 references

publication date

16 June 2010

1 reference

11 November 2017

1 reference

11 November 2017

376

1 reference

11 November 2017

9736

1 reference

11 November 2017

146-148

1 reference

Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis

11 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960839-2

7 January 2021

Opioid switching to improve pain relief and drug tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960839-2

7 January 2021

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960839-2

7 January 2021

Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960839-2

7 January 2021

Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960839-2

7 January 2021

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960839-2

7 January 2021

Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960839-2

7 January 2021

Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960839-2

7 January 2021

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960839-2

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960839-2

7 January 2021

Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960839-2

7 January 2021

10.1016/S0140-6736(10)60839-2

Identifiers

DOI

1 reference

11 November 2017

1 reference

PubMed ID

20638554